Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep >

News from the International Liver Congress 2022

News from the International Liver Congress 2022

Read our summary bulletin of news from the conference in English, Spanish, Russian, French and Portuguese.

Professor Heiner Wedemeyer of Hannover Medical School speaking at an International Liver Congress press conference. Photo © Steve Forrest & Andrew McConnell / EASL.Professor Heiner Wedemeyer of Hannover Medical School speaking at an International Liver Congress press conference. Photo © Steve Forrest & Andrew McConnell / EASL.

Hepatitis D

Bulevirtide leads to sustained improvement for people with hepatitis D.

Liver transplants

Liver transplants

Short-course treatment prevents hepatitis C after organ transplant.

Dr Kosh Agarwal discusses results of the REEF-2 study at the International LIver Congress. Photo © Steve Forrest & Andrew McConnell / EASL.Dr Kosh Agarwal discusses results of the REEF-2 study at the International LIver Congress. Photo © Steve Forrest & Andrew McConnell / EASL.

New & experimental hepatitis B treatments

Experimental hepatitis B combination suppresses key marker but fails to achieve functional cure.

Factsheets

Factsheets

Read our updated hepatitis C treatment factsheets on infohep.

infohep news

Latest library resources

Looking for country specific news and resources?

Looking for country specific news and resources?

Visit our country information pages >

Keep up to date with the latest hepatitis news

Keep up to date with the latest hepatitis news

Sign up for our free monthly email bulletin >